-
Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma
Bedke, J., Merseburger, A. S., Loriot, Y., Castellano, D., Choy, E., Duran, I., Rosenberg, J. E., Petrylak, D. P., Dreicer, R., Perez-Gracia, J. L., Hoffman-Censits, J. H., van der Heijden, M. S., Pavlova, J., Thiebach, L., de Ducla, S., Fear, S., Powles, T. & Sternberg, C. N., Sept 2021, In: European urology focus. 7, 5, p. 1084-1091 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial
van der Heijden, M. S., Loriot, Y., Durán, I., Ravaud, A., Retz, M., Vogelzang, N. J., Nelson, B., Wang, J., Shen, X. & Powles, T., Jul 2021, In: European urology. 80, 1, p. 7-11 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Yu, E. Y., Petrylak, D. P., O'Donnell, P. H., Lee, J.-L., van der Heijden, M. S., Loriot, Y., Stein, M. N., Necchi, A., Kojima, T., Harrison, M. R., Hoon Park, S., Quinn, D. I., Heath, E. I., Rosenberg, J. E., Steinberg, J., Liang, S.-Y., Trowbridge, J., Campbell, M., McGregor, B. & Balar, A. V., 1 Jun 2021, In: lancet oncology. 22, 6, p. 872-882 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
